In 1993, this column first discussed the theory that the Medical Device Amendments of 1976 (MDA) preempted state tort claims against medical device manufacturers. Since that time, two things have happened that make it timely to revisit this issue. First, the medical device industry has been visited with the largest settlement in products liability history - the proposed settlement of the litigation over silicone breast implants. The size of this settlement alone would make it important. It especially frightening because it is in the face of substantial medical evidence that silicone poses no significant risk of injury.
The second factor is that in the last two years there has been an avalanche of cases involving claims that the MDA preempts state tort claims against medical device manufacturers. The courts reviewing these cases have not been able to agree over the scope of preemption under the MDA, so this dispute will go to the United State Supreme Court. This article discusses the policy behind preemption under the MDA and why the United State Supreme Court should resolve this dispute in favor of medical device manufacturers.
The Climate Change and Public Health Law Site
The Best on the WWW Since 1995!
Copyright as to non-public domain materials
See DR-KATE.COM for home hurricane and disaster preparation
See WWW.EPR-ART.COM for photography of southern Louisiana and Hurricane Katrina
Professor Edward P. Richards, III, JD, MPH - Webmaster
Provide Website Feedback - https://www.lsu.edu/feedback
Accessibility Statement - https://www.lsu.edu/accessibility